BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Lighthouse Pharmaceuticals readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Lighthouse Pharmaceuticals's drug
 s run\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06847321-794@assetmemo.bio
DTSTAMP:20261121T005437Z
DTSTART;VALUE=DATE:20290131
DTEND;VALUE=DATE:20290201
SUMMARY:LHP588: Phase 2 readout est. (NCT06847321)
DESCRIPTION:LHP588\, phase 2\, Alzheimer's Disease.\nStudy: Study of LHP588
  in Subjects With P. Gingivalis-Positive Alzheimer's Disease\nEstimated pr
 imary completion: 31 January 2029. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/lhp588#upcoming-events\nRegistry record: https://clinicaltri
 als.gov/study/NCT06847321
URL:https://assetmemo.bio/drug/lhp588#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
